Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks

The next upside for Nifty Pharma is located above the resistance of 12,100 levels.

Pharma Stocks, Sun Pharma, Cadila, Cipla
The immediate support for Nifty Pharma index comes in at 10,800 levels.
Avdhut Bagkar Mumbai
3 min read Last Updated : Sep 17 2020 | 12:01 PM IST
Most pharma stocks have witnessed a huge upside so far in the calendar year 2020 (CY20). On a year-to-date (YTD) basis, the Nifty Pharma index has rallied over 45 per cent (as of Wednesday's close) as against nearly 5 per cent drop in the benchmark Nifty50 index, ACE Equity data show.

On Thursday, in the morning deals, the Nifty Pharma index was trading nearly 0.5 per cent higher at 11,742 levels with 6 out of 10 constituents advancing.  

Here's a look at what charts indicate for Nifty Pharma and some of its constituents. 

Nifty Pharma: A trendline breakout on the monthly chart indicates a positive trend for this index. This gets further confirmed by the Moving Average Convergence Divergence (MACD), which crossed the zero line in the upward direction. That said, the next upside is located above the resistance of 12,100 levels. The immediate support comes in at 10,800 levels. CLICK HERE FOR THE CHART
 
Dr Reddy's: A positive crossover of MACD and a consolidation breakout on the Relative Strength Index (RSI) suggest a strong bullishness going ahead, as per the daily chart. The weekly and monthly chart clearly suggests a trendline breakout above Rs 4,200 levels. All these trends signal a promising rally in the direction of Rs 5,200 levels in the near term. The support comes in at Rs 4,500 levels. CLICK HERE FOR THE CHART
 
Biocon Ltd (BIOCON): The new all-time high touched on Wednesday indicates a strong rally. This might not have received enough support from the volume, but the price is not signalling any downward reversal. The monthly chart reflects the firm ability of the counter to absorb the selling pressure in the range of Rs 450 to Rs 400, which it failed last time in July, 2020. The overall trend indicates a rally towards Rs 490 and Rs 515 levels. The closing basis support is placed at Rs 410 levels. CLICK HERE FOR THE CHART
 
Torrent Pharmaceuticals Ltd (TORNTPHARM): There is no looking back for this counter since it crossed Rs 2,000 level. This strength and momentum are still intact and the stock will continue to gain positive sentiment. With a consolidation breakout above Rs 2,620, the counter is set to rally above Rs 3,200 levels. The price is signalling an accumulation in the range of Rs 2,700 to Rs 2,900 levels, as per the daily chart. CLICK HERE FOR THE CHART

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Dr Reddy's Laboratories Limitedstocks to watchpharmaceutical firmsstocks technical analysistechnical analysis

Next Story